SEC Filing Details
Document Details
Form
Filing Date
Feb 28, 2019
Document Date
Feb 26, 2019
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Oramed Pharmaceuticals Inc.
Issuer
ORAMED PHARMACEUTICALS INC.
Filer
Hasleton Mark Daniel